Lotemax® (loteprednol etabonate) – Expanded indication
July 20, 2018 - The FDA announced the approval of Bausch and Lomb’s Lotemax (loteprednol etabonate) ophthalmic gel 0.5%, for the treatment of post-operative inflammation and pain following ocular surgery.
Download PDF
